share_log

Editas Medicine shares are trading lower after Morgan Stanley maintained an Underweight rating on the stock and lowered its price target from $17 to $15.

Editas Medicine shares are trading lower after Morgan Stanley maintained an Underweight rating on the stock and lowered its price target from $17 to $15.

在摩根士丹利维持对该股的减持评级并将其目标价从17美元下调至15美元后,Editas Medicine的股价下跌。
Benzinga ·  2022/05/09 10:56

Editas Medicine shares are trading lower after Morgan Stanley maintained an Underweight rating on the stock and lowered its price target from $17 to $15.

在摩根士丹利维持对该股的减持评级并将其目标价从17美元下调至15美元后,Editas Medicine的股价下跌。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发